A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer

被引：0
|
作者：
Takaaki Arigami
Daisuke Matsushita
Keishi Okubo
Masataka Shimonosono
Ken Sasaki
Yusuke Tsuruda
Yoshiaki Kita
Kan Tanabe
Shinichiro Mori
Shigehiro Yanagita
Yoshikazu Uenosono
Akihiro Nakajo
Hiroshi Kurahara
Takao Ohtsuka
机构：
[1] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Onco
[2] Kagoshima University Graduate School of Medical and Dental Sciences,Biological Surgery
来源：
Surgery Today | 2022年 / 52卷
关键词：
Gastric cancer; Conversion surgery; Prognosis; Trastuzumab; HER2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1721 / 1730
页数：9
相关论文
共 50 条
  • [1] A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer
    Arigami, Takaaki
    Matsushita, Daisuke
    Okubo, Keishi
    Shimonosono, Masataka
    Sasaki, Ken
    Tsuruda, Yusuke
    Kita, Yoshiaki
    Tanabe, Kan
    Mori, Shinichiro
    Yanagita, Shigehiro
    Uenosono, Yoshikazu
    Nakajo, Akihiro
    Kurahara, Hiroshi
    Ohtsuka, Takao
    SURGERY TODAY, 2022, 52 (12) : 1721 - 1730
  • [2] Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Van den Mooter, Tom
    Teuwen, Laure-Anne
    Rutten, Annemie
    Dirix, Luc
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 749 - 760
  • [3] Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Cortes, Javier
    Fumoleau, Pierre
    Bianchi, Giulia Valeria
    Petrella, Teresa M.
    Gelmon, Karen
    Pivot, Xavier
    Verma, Shailendra
    Albanell, Joan
    Conte, Pierfranco
    Lluch, Ana
    Salvagni, Stefania
    Servent, Veronique
    Gianni, Luca
    Scaltriti, Maurizio
    Ross, Graham A.
    Dixon, Joanna
    Szado, Tania
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1594 - 1600
  • [4] Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy
    Kadowaki, Shigenori
    Yatabe, Yasushi
    Nitta, Sohei
    Ito, Yuichi
    Muro, Kei
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 210 - 216
  • [5] Trastuzumab: A Milestone in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Dhanushkodi, Manikandan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 54 - 56
  • [6] Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab
    O'Mahony, Denis
    Power, Stephen P.
    Power, Derek G.
    LANCET, 2023, 401 (10378): : 772 - 772
  • [7] Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Yeo, Winnie
    Luk, M. Y.
    Soong, Inda S.
    Yuen, Tony Y. S.
    Ng, T. Y.
    Mo, Frankie K. F.
    Chan, K.
    Wong, S. Y.
    Tsang, Janice
    Leung, Carmen
    Suen, Joyce J. S.
    Ngan, Roger K. C.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 56 - 62
  • [8] Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Jitawatanarat, Potjana
    O'Connor, Tracey L.
    Kossoff, Ellen B.
    Levine, Ellis G.
    Chittawatanarat, Kaweesak
    Ngamphaiboon, Nuttapong
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 356 - 362
  • [9] Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer
    Inoue, Hiroaki
    Horii, Rie
    Ito, Yoshinori
    Iwase, Takuji
    Ohno, Shinji
    Akiyama, Futoshi
    BREAST CANCER, 2018, 25 (03) : 268 - 274
  • [10] Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer
    Hiroaki Inoue
    Rie Horii
    Yoshinori Ito
    Takuji Iwase
    Shinji Ohno
    Futoshi Akiyama
    Breast Cancer, 2018, 25 : 268 - 274
12345